HSP90-IN-9 is a potent and selective HSP90 inhibitor; exhibits dose-dependent antifungal activity; in combination with fluconazole (FLC), inhibits fungal biofilm formation and morphological transitions; restores FLC sensitivity in resistant strains by downregulating the expression of ERG11, CDR1, and CDR2 genes.